Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I like the $4.65 step...
Wow, 23,953! Huge volume here, less than $60,000! Has everyone placed thier bets?
Have they resolved the supply and refinement issue?
So what is an adverse effect? 98%, numbers are funny aren't they. Looking at a number out of context means nothing. Please describe the actual concern and if the effects were severe, persistent and how long they were observed.
About $2.55 worth...
Hmmm, mid $2.50's by EOD again? Appears to run a little through the day, then sold back down at the end...
Hydrogen?
A short position should trade frequently to maximize profits. There is additional risk, but returns diminish quickly with a declining stock price if the position is held, and increase significantly with each trade on a declining price. If profit taking, a short position would stay the same in terms of quantity. If rolling profits a short position would increase in quantity the lower the price goes.
Whoops! Priceless
4.76% not too bad right? Good to see people still keeping it real and realizing a gain when they see one. Nice to meet you Amazed.
I think we may have to wait until Friday...
Are we heading back up yet?
I like your thinking!
Great! Did we patent those discoveries so investors can make some money?
There is no time line attached to this statement. They could file every quarter or annually after the sale and still meet these terms.
Interesting. So do you think he communicated $250 million to intentionally make investors think the value of the company was going to rise? To raise $250 million the valuation would certainly rise significantly. Why would he do this?
Just to be clear... you are saying that they must file a Prospectus each time they plan to sell shares going forward? Hey, we plan to sell 100,000 shares on Wednesday for $2.14. Then we plan to sell 200,000 shares on Thursday for $1.60. Interesting.
Looks like $2.14 is back on the table.
Well the leaked news didn't last long...
You're right again. The problem inlies with the efficacy of A2-73. If the MOA is unsupported, the data gathered certainly offers insight into how gut microbia relates to the effects of A2-73, but it would not demonstrate much beyond that. Precision medicine works if there is a positive effect to draw from, and that is certainly the hope here. It increases the likelihood of A2-73 being marketable if any positive effect is observed. If a positive effect is observed in a smaller percentage of a large population AND the effect can be linked to some/any markers, then the precision medicine approach has worked. If the effect cannot be linked, there is no benefit. The governments and investors would have to determine how much they would want to spend at that point to find the link for the relative size of the sample population. The greater hope is that there is a positive effect with markers identified and those markers provide insight into other approaches to treat alzheimers.
Worst case scenario is that there is no benefit observed.
I like you Xena. You're absolutely right. Most investors are looking for a return on investment, so unless those answers point to something we (Anavex) own, the answers to those questions likely won't get answered with our investment. We're not funding a precision medicine experiment, we are funding a trial in hope to find our drug is marketable.
So is that one pill per patient per day?
Hmmm, initial results. From and old study? Seems contradictory. What relevance is initial gut data if it does not relate to efficacy?
1. How much inventory is that exactly?
2. Because that is what any hopeful biotech would do.
3. Because we all need a paycheck.
4. Because they are hopeful that it will translate.
Just say'n.
I would put advisors in the same group as message board posters.
Certainly it will reach a point where it will or it wont. We all hope we're on the right side of the trade.
Tick Tock
Just taking a guess, but we should have 5 week data for about 90 randomized patients... interesting. I wonder how this data correlates to the 2a trial. I also wonder if any 3 or 6 month data will be available?
I see this all the time "someone is trying to scare you out of your shares". Wouldn't this have to be reported? Wouldn't this be easy to figure out? So if this someone were going to such an effort, surely they could afford a mere 5% of this company. It's not like it is valued that high.
I think that the market currently doesn't value Anavex that highly because of thier history and lack of meaningful progress.
Meaningful = today's dollars not the hopeful future
With a few safe trades in a leveraged etf, it's a wash.
What tool do you use to make that? I had a different target closer to $3 before the bounce.
All the arrows are pointing sideways or down...
I had 3.02 to 3.17 near term. Hope you're right.
Agreed. Their communicated position and expectation has been clear.
• Sufficient cash including non-dilutive grant and governmental third party support to fund objectives for the next 2 years
Thanks George. Should be interesting, the next couple of weeks.
I don't get it George. How does this add value?
Only if that capital alone makes the companies increase in value greater than the loss in your percentage of ownership in the company.
Plain and simple.
Let me throw this out there... many believe the clinical trials will be successfull. If we dilute now, and the trials are successful, and the value of the company increases significantly before that additional capital is spent, the original investors got screwed. The raised capital alone has to bring the additional increase in valuation, not any efforts that are already underway that are already paid for by current investors.
Dilution does reduce the value of your shares. Plain and simple. If there is some event or interest that increases the valuation of the company, it has nothing to do with the dilution, and you still own a smaller percentage of the company.
$1,000,000 valuation with 1,000,000 shares is $1/sh.
$1,000,000 valuation with 2,000,000 shares is $.50/sh.
$2,000,000 valuation with 2,000,000 shares means you got screwed unless the additional capital alone adds value beyond this point.